|
Information For:
|
Revision BulletinTerbinafine Hydrochloride
In accordance with the Rules and Procedures of the 2005–2010 Council of Experts, the Monograph Development-Antiviral and Antimicrobials Expert Committee has approved the Terbinafine Hydrochloride Monograph Revision Bulletin. The Revision Bulletin deletes the Melting range test to align with the specifications in newly approved ANDAs. The proposed revision in Pharmacopeial Forum volume 34(5) to reflect limited approved specifications is cancelled. The Terbinafine Hydrochloride Monograph Revision Bulletin supersedes the monograph in USP 32–NF 27 until it is printed in the USP 32–NF 27 Second Supplement, which will be released June 1, 2009. Should you have any questions, please contact Behnam Davani, Ph.D., (301–816–8394 or bd@usp.org). Download the Terbinafine Hydrochloride Monograph Transferred to Accelerated Revision History section: 26 February 2010 What's New
![]() USP recalled USP 33-NF 28 on Jan. 8, 2010. A reissue product will be available in April 2010.
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||